Process View
The process in which a low-density lipoprotein particle is removed from the blood via receptor-mediated endocytosis and its constituent parts degraded.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "low density lipoprotein particle clearance"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| C1QA | complement component 1, q subcomponent, A chain | 0.731 | Human | |
| C1QC | complement component 1, q subcomponent, C chain | 0.706 | Human | |
| RBFOX1 | RNA binding protein, fox-1 homolog (C. elegans) 1 | 0.278 | ||
| PCBP1 | poly(rC) binding protein 1 | 0.276 | ||
| RBFOX2 | RNA binding protein, fox-1 homolog (C. elegans) 2 | 0.157 | ||
| PAG1 | phosphoprotein associated with glycosphingolipid microdomains 1 | 0.153 | ||
| APOA1 | apolipoprotein A-I | 0.127 | ||
| HNRNPA0 | heterogeneous nuclear ribonucleoprotein A0 | 0.121 | ||
| KHDRBS1 | KH domain containing, RNA binding, signal transduction associated 1 | 0.118 | ||
| PTBP2 | polypyrimidine tract binding protein 2 | 0.100 | ||
| HNRNPH2 | heterogeneous nuclear ribonucleoprotein H2 (H') | 0.072 | ||
| U2AF2 | U2 small nuclear RNA auxiliary factor 2 | 0.055 | ||
| LDLR | low density lipoprotein receptor | 0.045 | ||
| ALB | albumin | 0.041 | ||
| ANKFY1 | ankyrin repeat and FYVE domain containing 1 | 0.040 | ||
| CIRBP | cold inducible RNA binding protein | 0.033 | ||
| HNRNPH3 | heterogeneous nuclear ribonucleoprotein H3 (2H9) | 0.032 | ||
| DDX5 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 | 0.030 | ||
| DKK1 | dickkopf homolog 1 (Xenopus laevis) | 0.027 | ||
| LRRK2 | leucine-rich repeat kinase 2 | 0.026 | ||
| PCSK9 | proprotein convertase subtilisin/kexin type 9 | 0.026 | ||
| QKI | quaking homolog, KH domain RNA binding (mouse) | 0.024 | ||
| HNRNPH1 | heterogeneous nuclear ribonucleoprotein H1 (H) | 0.024 | ||
| SIGLEC1 | sialic acid binding Ig-like lectin 1, sialoadhesin | 0.023 | ||
| DDX17 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 17 | 0.021 | ||
| FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 0.019 | ||
| PDIA3 | protein disulfide isomerase family A, member 3 | 0.019 | ||
| RBMX | RNA binding motif protein, X-linked | 0.019 | ||
| PCBP2 | poly(rC) binding protein 2 | 0.018 | ||
| C1QB | complement component 1, q subcomponent, B chain | 0.018 | Human | |
| TRAF5 | TNF receptor-associated factor 5 | 0.017 | ||
| PRKCZ | protein kinase C, zeta | 0.016 | ||
| STON2 | stonin 2 | 0.015 | ||
| MICALL1 | MICAL-like 1 | 0.014 | ||
| ATXN1 | ataxin 1 | 0.014 | ||
| FYN | FYN oncogene related to SRC, FGR, YES | 0.014 | ||
| MARCO | macrophage receptor with collagenous structure | 0.013 | ||
| RHOG | ras homolog gene family, member G (rho G) | 0.012 | ||
| MTAP | methylthioadenosine phosphorylase | 0.012 | ||
| APOB | apolipoprotein B (including Ag(x) antigen) | 0.011 | ||
| APOE | apolipoprotein E | 0.011 | ||
| HNRNPU | heterogeneous nuclear ribonucleoprotein U (scaffold attachment factor A) | 0.011 | ||
| TOP1 | topoisomerase (DNA) I | 0.011 | ||
| LILRB1 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1 | 0.010 |